Reactions 1680, p267 - 2 Dec 2017 Extrapyramidal side effects: case report A 48-year-old man developed extrapyramidal side effects during treatment with olanzapine and risperidone. The man had a history of bilateral otitis media and had undergone bilateral myringoplasty at the age of 18 years. At the age of 38 years, he presented with psychiatric symptoms, for which he received risperidone. Following 9.5 years of this treatment, his symptoms worsened for several times due to the discontinuation of treatment. However, after commencing individual treatment with olanzapine 20mg and risperidone 8mg for three weeks each [route not stated], the symptoms persisted. He developed extrapyramidal side effects [duration of treatment to reaction onset and outcome not stated]. The man’s antipsychotic therapy was switched to trifluoperazine and he received trihexyphenidyl to manage extrapyramidal side effects. Author comment: ’’Despite individual treatment with risperidone 8 mg and olanzapine 20 mg for 3weeks each, the symptoms did not improve. However, within 2 weeks of switching to trifluoperazine 30 mg and trihexyphenidyl 4–6 mg (to manage extrapyramidal side effects), his psychotic symptoms improved completely’’. Jain S, et al. Improvement of tinnitus with trifluoperazine in a patient with psychosis and ear disease. Asian Journal of Psychiatry 30: 177-178, Dec 2017. Available from: URL: http://doi.org/10.1016/j.ajp.2017.10.027 - India 803284172 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera